Funding Details
- Date Award
- May 13, 2024
- Vertical
- Industrial and Research Tools
- Funding URL
- View Funding Page
Company Info
- Founders
- Michael Lukesch
- Company Description
- Valanx Biotech is a university spin-out offering a patented method for high-efficiency protein conjugation for cancer drug targeting and other uses. Through the power of synthetic biology and genetic-code expansion, we have developed a novel site-specific protein conjugation platform that allows precise control over a conjugation site and the number of conjugations on the protein of interest.
- Location
-
Austria
Links